This year's conference will be held October 18-19 at:
DoubleTree by Hilton
3203 Quebec Street
Denver, Colorado 80207
Click the title ("Conference Location" to book your room!
Click on the above title ("Directions") for detail information on your options to get to the conference location (DoubleTree by Hilton) from Denver International Airport
Local Emergency Medical Attention
St Joseph Hospital 1375 E 19th Ave, Denver CO 80218 (5.3 mi) 303.812.2000
Rose Medical Center 4567 E 9th Ave, Denver CO 80220 (4.3mi) 303.320.2121)
The little Clinic 2810 Quebec St, Denver CO 80207 (0.6mi) 303.370.5870 Inside King Soopers
CareNow Urgent Care 3001 Havana St, Denver CO 80238 (2.1mi) 720.458.6825
Local Pharmacy and Grocery
Walgreens Pharmacy 7311 E 29th Dr, Denver CO 80238 (0.4mi) 720.214.5332
Sam’s Club Pharmacy 7805 E 35th Ave, Denver CO 80238 (0.7mi) 720.941.6180
King Soopers Grocery 2810 Quebec St, Denver CO 80207 (0.6mi) 303.333.3223
Please click on the link above for the Conference schedule as of 10 Oct. Additional information may be provided as available.
Michael Mannstadt, MD is Chief of the Endocrine Unit at the Massachusetts General Hospital and Associate Professor in Medicine at Harvard Medical School. His clinical and research interests focus on diseases of the parathyroid glands. He is particularly interested in hypoparathyroidism, and his research spans the basic, translational, and clinical realms of the disease. He is the principal investigator of an NIH grant for the development of a long-acting PTH, and the lead author of the phase 3 clinical trial of PTH(1-84) in hypoparathyroidism. Dr. Mannstadt also hopes that the Natpara recall is soon over. He is a medical advisor for the Hypoparathyroid Association and a frequent faculty participant at their annual patient meetings.
Dr. Dolores Shoback is Professor of Medicine and Associate Program Director of the Fellowship Program in Diabetes, Endocrinology and Metabolism at the University of California, San Francisco School of Medicine. She graduated from the University of Pennsylvania (BA, Biology) and Johns Hopkins University School of Medicine (MD). After Medicine residency at Johns Hopkins Hospital and fellowship in Endocrinology and Hypertension at the Brigham and Women’s Hospital/Harvard Medical School, she joined the faculty in 1985 in the Endocrine Research Unit at the San Francisco Veterans Affairs Medical Center and the University of California, San Francisco. She is active in basic and clinical research involving calcium-sensing receptors, parathyroid disorders, and calcium-sensing receptors. She has authored more than 150 research papers, reviews and chapters and co-edited the last 3 editions of the Greenspan Textbook of Endocrinology and Metabolism.
Lynn Kohlmeier, M.D. received her undergraduate degree from Yale University, in New Haven, Connecticut, and her medical degree from Stanford University School of Medicine in Stanford, California. Dr Kohlmeier was a resident in internal medicine at the New England Deaconess Hospital at Harvard Medical School in Boston, Massachusetts, and returned to Stanford for her endocrinology fellowship. As a Clinical Investigator in the Endocrinology Hypertension Division, Skeletal Health and Osteoporosis at Harvard Medical School, she was involved in clinical and basic science research. She received a Young Investigator Award for her work with the calcium-sensing receptor.
Dr. Kohlmeier has been director of Endocrinology and Spokane Osteoporosis as an independent practitioner, since moving to Spokane in 1999. She founded and continues to coordinate the Spokane Bone Club, an annual dinner meeting with nationally renown guest speakers, providing state-of-the-art bone health education.
Dr Kohlmeier and her staff joined Spokane Internal Medicine for four years in 2014, and are now working in rural clinics in Eastern Washington and Northern Idaho. Dr. Kohlmeier founded Strong Start in 2001, and with her trusted DXA technicians, and continues to monitor DXA BMD quality providing reports and osteoporosis guidelines for DXA sites throughout the Northwest.
Dr Kohlmeier's involvement as Principal Investigator and Sub-Investigator in research studies on bone mineral density, bone quality tests, fracture assessment, and osteoporosis, has resulted in multiple publications. She is a reviewer for the Journal of Clinical Densitometry, Metabolism, and Osteoporosis International, and is an executive board member for Advances in Mineral Metabolism/American Society for Bone and Mineral Research. Dr Kohlmeier is recognized as a national speaker for metabolic bone disease and osteoporosis. She gives presentations on parathyroid and thyroid disease, testosterone and estrogen replacement, vitamin D as well as rare bone disease to primary care providers, specialists, medical students, physician assistant and nurse practitioner students and family medicine residents.
Dr Kohlmeier is co-founder and director of the non-profit Strides for Strong Bones, with Marla Emde, organizing community bone density screening and education events, as well as an annual walk/run in Medical Lake, Washington. With the help of many volunteers, she has organized hundreds of ‘Osteoporosis’ triathlon teams and provided free bone density screening and osteoporosis education for thousands of men and women at the annual Westplains Wunderwoman Triathlon for Osteoporosis Awareness, now known as TRI and DU it for Strong Bones.